Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease Trial Phase 2 Withdrawn Jan. 6, 2025
Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease Trial N/A Not yet recruiting Jan. 6, 2025
A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease Trial Phase 2 Withdrawn Jan. 6, 2025
Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. Trial N/A Not yet recruiting Dec. 31, 2024
Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease Trial N/A Completed Dec. 26, 2024
Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation Trial N/A Completed Dec. 26, 2024
Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3) Trial N/A Completed Dec. 19, 2024
Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Trial N/A Recruiting Dec. 18, 2024
Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration Trial N/A Completed Dec. 17, 2024
An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD Trial N/A Completed Dec. 17, 2024
A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease Trial N/A Recruiting Dec. 16, 2024
fMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's Disease Trial N/A Completed Dec. 15, 2024
Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease Symptoms Trial N/A Completed Dec. 12, 2024
Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease Trial N/A Recruiting Dec. 10, 2024